Is Goldman Sachs Poised for a Big Win?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Is Goldman Sachs Poised for a Big Win?

© Creative Commons / Wikimedia Commons

Goldman Sachs Group Inc. (NYSE: GS | GS Price Prediction) is set to report its most recent quarterly results before the markets open on Wednesday. Analysts expect to see $5.46 in earnings per share (EPS) and $8.51 billion in revenue. The fourth quarter of last year reportedly had $6.04 in EPS and $8.08 billion in revenue.

During the most recent quarter, Investing & Lending net revenues included record quarterly net interest income in debt securities and loans. Also, Investment Management net revenues included record quarterly management and other fees.

The third-quarter results reflected the underlying strength in the global client franchise and its ability to produce solid results in the context of a mixed operating environment. However, with Goldman Sachs’ focus on investing in growth opportunities, the rising tide of the past quarter could prove beneficial for the investment bank.

If the Goldman Sachs quarterly report is anything like JPMorgan’s fourth quarter, then trading revenues will be a big factor.

Overall, Goldman Sachs stock has outperformed the broad markets, up about 38% in the past 52 weeks. In the past quarter alone, the stock is up 20%.

[nativounit]

A few analysts weighed in on the investment bank ahead of the report:

  • Piper Sandler has an Overweight rating.
  • JMP Securities rates it Outperform with a $290 price target.
  • Buckingham Research has a Buy rating and a $290 price target.
  • Merrill Lynch has a Buy rating and a $270 target price.
  • D.A. Davidson’s Buy rating comes with a $272 price target.
  • RBC has a Neutral rating and a $220 target price.
  • Barclays has a Hold rating with a $267 price target.

Shares of Goldman Sachs traded at $246.30 on Tuesday, in a 52-week range of $176.40 to $246.44. The consensus price target is $257.25.

[recirclink id=635175]
[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618